scispace - formally typeset
G

Gerard McCann

Researcher at Medicines and Healthcare Products Regulatory Agency

Publications -  14
Citations -  583

Gerard McCann is an academic researcher from Medicines and Healthcare Products Regulatory Agency. The author has contributed to research in topics: Randomized controlled trial & Cluster randomised controlled trial. The author has an hindex of 9, co-authored 12 publications receiving 518 citations. Previous affiliations of Gerard McCann include University of London.

Papers
More filters
Journal ArticleDOI

Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices.

TL;DR: Most UK general practices prescribe antibiotics to young and middle-aged adults with respiratory infections at rates that are considerably in excess of what is clinically justified, which will fuel antibiotic resistance.
Journal ArticleDOI

Electronic Health Records for Intervention Research: A Cluster Randomized Trial to Reduce Antibiotic Prescribing in Primary Care (eCRT Study)

TL;DR: Cluster randomized trials may be implemented efficiently in large samples from routine care settings by using primary care electronic health records and future studies should develop and test multicomponent methods for remotely delivered intervention.
Journal ArticleDOI

Cluster randomised trial in the General Practice Research Database: 1. Electronic decision support to reduce antibiotic prescribing in primary care (eCRT study).

TL;DR: A cluster randomised trial is implemented to test the effectiveness of an electronic record-based intervention at achieving a reduction in antibiotic prescribing at consultations for respiratory illness in patients aged 18 and 59 years old in intervention family practices as compared with controls.
Journal ArticleDOI

Cluster randomized trials utilizing primary care electronic health records: Methodological issues in design, conduct, and analysis (eCRT Study)

TL;DR: Cluster randomized trials may be performed efficiently in large samples from UK general practices using the electronic health records of a primary care database, and the geographical dispersal of trial sites presents a difficulty for research governance approval and intervention implementation.